skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Nanoimaging to Prevent and Treat Alzheimer’s and Parkinson’s Diseases. Scientific/Technical report

Technical Report ·
DOI:https://doi.org/10.2172/1057905· OSTI ID:1057905

This project will develop innovative approaches to characterization of the very early stages of protein aggregation that eventually can be translated to the development of early diagnostic tools and efficient treatments for Alzheimer’s, Parkinson’s and Huntington’s diseases. Funding will be used to acquire nanoimaging technology for nanoscale imaging, manipulation and analysis of biomedical materials to develop treatments that will repair disabled proteins and cure diseases that result from protein malfunction, specifically Alzheimer’s and Parkinson’s diseases. Expected outcomes include tests for early diagnosis and therapeutic treatments for these devastating neurological diseases. To elucidate the mechanisms of protein misfolding, we will establish an extensive program of experimental studies using a broad arsenal of advanced nanoscale and traditional techniques that will be integrated with molecular-scale modeling of protein misfolding and the nucleation of aggregate structures. To identify intracellular machinery or/and multicomponent complexes critically involved in protein misfolding, we will characterize interactions between targeted proteins and specific intracellular components or metabolites that impact on protein conformational pathways leading to protein misfolding accompanied by formation of toxic aggregated morphologies. To design innovative nanotechnology tools for the control of intracellular protein misfolding and aggregation processes, we will develop a predictive molecular scale model for intracellular protein misfolding and the formation of toxic aggregates. Verified through experimental studies, the objective is to establish an enabling foundation for the engineering of novel molecular diagnostics and therapeutics for various cellular pathologies.

Research Organization:
University of Nebraska Medical Center, Omaha, Nebraska
Sponsoring Organization:
USDOE NA Office of Infrastructure and Environment (NA-50); USDOE Office of Science (SC)
DOE Contract Number:
FG02-08ER64579
OSTI ID:
1057905
Report Number(s):
DOE/ER64579
Country of Publication:
United States
Language:
English

Similar Records

Predictive Big Data Analytics: A Study of Parkinson’s Disease Using Large, Complex, Heterogeneous, Incongruent, Multi-Source and Incomplete Observations
Journal Article · Fri Aug 05 00:00:00 EDT 2016 · PLoS ONE · OSTI ID:1057905

Small heat shock proteins protect against {alpha}-synuclein-induced toxicity and aggregation
Journal Article · Fri Dec 22 00:00:00 EST 2006 · Biochemical and Biophysical Research Communications · OSTI ID:1057905

Hemin as a generic and potent protein misfolding inhibitor
Journal Article · Fri Nov 14 00:00:00 EST 2014 · Biochemical and Biophysical Research Communications · OSTI ID:1057905

Related Subjects